Study of GC101 TIL in Brain Glioma (Soochow2)
NCT04943913
·
clinicaltrials.gov ↗
EARLY_PHASE1
Phase
RECRUITING
Status
50
Enrollment
INDUSTRY
Sponsor class
Conditions
Glioma
Interventions
BIOLOGICAL:
Tumor Infiltrating Lymphocytes (TIL)
Sponsor
Shanghai Juncell Therapeutics
Collaborators
[object Object]